Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Heptares Collaboration With AstraZeneca Yields New Insights to Advance Drug Discovery in Pain, Cancer and Inflammation
Thursday, April 27, 2017Heptares Therapeutics Heptares the whollyowned subsidiary of Sosei Group Corporation TSE Mothers Index describes new insights for drug discovery from the first resolved highresolution Xray crystal structures of the ProteaseActivated Receptor PAR in...
DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083
Wednesday, April 26, 2017DelMar Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of new cancer therapies today announced that it has entered into a threeyear collaboration with Duke University to evaluate VAL the Companys platf...
AstraZeneca's lung cancer drug Tagrisso receives full approval in the EU
Wednesday, April 26, 2017AstraZeneca announced that the European Commission EC has granted full marketing authorisation for Tagrisso osimertinib mg and mg oncedaily tablets for the treatment of adult patients with locallyadvanced or metastatic epidermal growth factor recepto...
Akebia Therapeutics and Otsuka Pharmaceutical Expand Relationship with Collaboration to Develop and Commercialise Vadadustat
Wednesday, April 26, 2017Akebia Therapeutics Inc and Otsuka Pharmaceutical Co Ltd announced that they have expanded their collaboration for vadadustat by entering into a collaboration and license agreement for Europe China and other territories Vadadustat is an oral hypoxiai...
Servier and CTI BioPharma Expand License and Collaboration Agreement
Tuesday, April 25, 2017Servier and CTI BioPharma Corp jointly announced that they agreed to expand their existing license and development collaboration agreement for PIXUVRI pixantrone Under this expanded agreement Servier will have rights to PIXUVRI in all markets except...
Orexigen Therapeutics Announces New Drug Submission for Contrave© in Canada
Tuesday, April 25, 2017Orexigen Therapeutics Inc a biopharmaceutical company helping to improve the health and lives of patients struggling with weight loss today announced that Health Canada has completed its screening phase and accepted for review a New Drug Submission f...
Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab)
Tuesday, April 25, 2017Novartis today announced an expanded commercialization agreement with Amgen for AMG erenumab which is being investigated for the prevention of migraine This agreement builds on a global collaboration between Novartis and Amgen and leverages almost...
Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib
Monday, April 24, 2017Tiziana Life Sciences plc a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases today announces the approval in Israel of a phase II clinical trial protocol for testing milciclib a novel inhibitor of cell...
Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab)
Monday, April 24, 2017Regeneron Pharmaceuticals Inc and Sanofi today announced that the European Medicine Agencys EMA Committee for Medicinal Products for Human Use CHMP has adopted a positive opinion for the marketing authorization of Kevzara sarilumab recommending its a...
H3 Biomedicine Extends Collaboration with Foundation Medicine to Develop Precision Therapies for Cancer
Friday, April 21, 2017H Biomedicine Inc a clinical stage biopharmaceutical company specializing in the discovery and development of precision medicines for oncology and a member of Eisais global Oncology Business Group today announced that is has extended its multiyear co...
